The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients

CompletedOBSERVATIONAL
Enrollment

158

Participants

Timeline

Start Date

July 31, 2018

Primary Completion Date

February 26, 2020

Study Completion Date

February 26, 2020

Conditions
Kidney Transplant
Interventions
DRUG

Immunosuppressive

Immunosuppressive therapies

Trial Locations (12)

Unknown

A.O.U. Consorziale Policlinico, Bari

A.O.U. Policlinico S.Orsola Malpighi, Bologna

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan

A.O.U. Maggiore della Carità, Novara

Azienda Ospedaliera di Padova, Padua

ARNAS Ospedale Civico, Palermo

A.O.U. Pisana P.O. Cisanello, Pisa

Ospedale Cisanello, Pisa

Fondazione Policlinico Univ. Gemelli, Roma

A.O.U. Città della Salute e della Scienza, Torino

A.O. Ospedale Circolo e Fondazione Macchi, Varese

A.O.U.I. Ospedale Borgo Trento, Verona

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT03558373 - The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter